hotspot -WSS

hotspot

author：explore 2025-10-01 01:00:12 - browse：12969

The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned.

One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT. Eisai, the drugmaker behind lecanemab, disagreed, pointing to other possible factors, including a series of setbacks in preceding months — multiple falls, a heart attack, a respiratory infection, and mini-stroke-like events.

Though still under investigation, the death suggests that new medicines to treat Alzheimer’s, like medicines to treat anything else, will come with their own side effects and costs. It also raises the importance of waiting for the full lecanemab data before drawing conclusions based on the positive press release put out by Eisai and its partner Biogen last month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Pentagon will tighten controls on classified information after Discord leak

WSS

Following judge's order, DOJ releases slightly less

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

First over

Medicare drug price negotiation continues, as pharma counteroffers

$1 billion proposal to grow Boston, Massachusetts biotech

Search warrant issued in 1996 disappearance of Kristin Smart

explore

hotspot

explore

At least 13 dead in Texas as scorching temps continue

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

Dobbs anniversary: the lost opportunity of abortion as health care

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Florida health officials providing scant details on measles cases

United colonoscopy coverage change 'may cost lives,' doctors say

Condition critical? Britain's beloved but battered National Health Service turns 75

Medical records are filled with copy

Pregnant women don't need prenatal multivitamins, study concludes

hotspot

Harvard's David Sinclair gets blowback over aging

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

Longer MASH drug regimen improved liver, Akero study finds

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Immune cells and nerve overgrowth may explain recurring UTI pain

Florida health officials providing scant details on measles cases

focus

Wikipedia

focus

hotspot